Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_220d0170074b3f5eaf047b178c967259 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2011-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d12a187af585ae51570665fb5ca7076d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c03dbcc9f612c36c1143ebec69d8bf4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7369737c68bf0fcfef9e970eb11f9ef |
publicationDate |
2016-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2578513-T3 |
titleOfInvention |
Aqueous solution comprising 3-quinuclidinone for the treatment of hyperproliferative, autoimmune and cardiac diseases |
abstract |
An aqueous solution of a compound of formula (I) ** Formula ** or a pharmaceutically acceptable salt thereof, wherein: R1 is selected from H-CH2-O-R3; R2 is -CH2-O-R3; and each R3 is independently selected from H and methyl; and a pH regulating agent; wherein the aqueous solution has a pH of 3.0 to 5.0. |
priorityDate |
2010-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |